Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2207434
Max Phase: Preclinical
Molecular Formula: C23H26N8O2
Molecular Weight: 446.52
Molecule Type: Small molecule
Associated Items:
ID: ALA2207434
Max Phase: Preclinical
Molecular Formula: C23H26N8O2
Molecular Weight: 446.52
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1cnc(-c2cc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc(C)cc3)n[nH]2)cn1
Standard InChI: InChI=1S/C23H26N8O2/c1-14-6-8-15(9-7-14)31-20(11-18(30-31)23(2,3)4)27-22(32)26-19-10-16(28-29-19)17-12-25-21(33-5)13-24-17/h6-13H,1-5H3,(H3,26,27,28,29,32)
Standard InChI Key: LQSULSOEXLYODN-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 446.52 | Molecular Weight (Monoisotopic): 446.2179 | AlogP: 4.31 | #Rotatable Bonds: 5 |
Polar Surface Area: 122.64 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 10 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 8.65 | CX Basic pKa: 1.95 | CX LogP: 4.59 | CX LogD: 4.57 |
Aromatic Rings: 4 | Heavy Atoms: 33 | QED Weighted: 0.42 | Np Likeness Score: -1.88 |
1. Bhattacharya SK, Aspnes GE, Bagley SW, Boehm M, Brosius AD, Buckbinder L, Chang JS, Dibrino J, Eng H, Frederick KS, Griffith DA, Griffor MC, Guimarães CR, Guzman-Perez A, Han S, Kalgutkar AS, Klug-McLeod J, Garcia-Irizarry C, Li J, Lippa B, Price DA, Southers JA, Walker DP, Wei L, Xiao J, Zawistoski MP, Zhao X.. (2012) Identification of novel series of pyrazole and indole-urea based DFG-out PYK2 inhibitors., 22 (24): [PMID:23153798] [10.1016/j.bmcl.2012.10.039] |
Source(1):